Understanding and controlling the variables for stromal vascular fraction therapy

doi:10.4252/wjsc.v16.i8.784

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 8

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (1538)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-8) series.

Item

Count

PDF

HTML

928

Figures (1-2)

106

Tables (1-8)

112

Sum=1195

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

125

Sum=200

Publishing Process of This Article

Item

Count

Browse

Download

Sum=89

Aug 26, 2024 (publication date) through Dec 25, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Stem Cells

ISSN

1948-0210

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Stem Cells. Aug 26, 2024; 16(8): 784-798
Published online Aug 26, 2024. doi: 10.4252/wjsc.v16.i8.784

Table 2 Comparative analysis of autologous vs allogenic stromal vascular fraction sources

SVF source	Advantages	Disadvantages
Autologous SVF	Eliminates immune rejection. No donor disease transmission. Enables personalized treatments	Requires surgical adipose extraction. Variable SVF quality and quantity
Allogenic SVF	Avoids surgery for each patient. Steady, ready supply. Beneficial for patients with scant adipose tissue	Possible immune response. Risk of disease if donor screening is lax

SVF: Stromal vascular fraction.

Citation: Jeyaraman N, Shrivastava S, Ravi V, Nallakumarasamy A, Pundkar A, Jeyaraman M. Understanding and controlling the variables for stromal vascular fraction therapy. World J Stem Cells 2024; 16(8): 784-798
URL: https://www.wjgnet.com/1948-0210/full/v16/i8/784.htm
DOI: https://dx.doi.org/10.4252/wjsc.v16.i8.784